Congratulations to the IDIGH Program PIs who have received grants to understand and fight COVID-19:

MI4 Emergency COVID—19 Research Funding (Round 1)

*IDIGH PIs in bold

  • Drs. Matthew Cheng, Erwin Schurr and Guillaume Bourque titled: Genomic biomarkers to predict outcome and treatment response in hospitalized COVID-19 patients
  • Drs. Jorg H. Fritz and Ciriaco A. Piccirillo titled: Defining the protective host immune response to SARS-CoV-2
  • Drs. Todd C. Lee, Emily G. McDonald and Matthew P. Cheng, titled: Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial (COVID19 PEP RCT – Canada)
  • Drs. Matthew P. Cheng, Leighanne O. Parkes, Todd C. Lee and Emily G. McDonald, titled: A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients in Canada (CATCO)

For more information on this grant and to view the full list of grant recipients, click here.

CIHR—Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity